Table 4 Number of extra MACEs in the control groups
Data items | Routine Therapy | Total | |||
|---|---|---|---|---|---|
Reperfusion | P2Y12 receptor inhibitors | Statins | Anticoagulants | ||
No. of redundant RCTs (%) | 210 (53.8) | 109 (27.9) | 59 (15.1) | 12 (3.1) | 390 (100.0) |
No. of patients in the control group (%) | 9714 (51.6) | 5379 (28.6) | 3,039 (16.1) | 687 (3.7) | 18819 (100.0) |
Extra MACEs (95%CI) | |||||
 Death | 617 (562, 672) | 253 (215, 290) | 159 (129, 189) | 62 (45, 80) | 1091 (1014, 1165) |
 Myocardial infarction | 154 (127, 182) | 251 (213, 287) | 161 (129, 193) | 10 (2, 19) | 576 (519, 633) |
 Revascularization | 0 (0, 0) | 20 (10, 29) | 12 (5, 18) | 0 (0, 0) | 31 (19, 42) |
 Stroke | 0 (0, 0 ) | 10 (2, 18) | 29 (17, 41) | 0 (0, 0) | 39 (23, 54) |
 Heart failure | 422 (372, 472) | 85 (61, 110) | 123 (96, 148) | 116 (94, 139) | 744 (679, 810) |
 Angina pectoris | 343 (299, 387) | 294 (253, 335) | 149 (119, 180) | 38 (23, 54) | 823 (754, 893) |
 Unspecified MACEs | 0 (0, 0) | 4 (2, 7) | 0 (0, 0) | 0 (0, 0) | 4 (2, 7) |
 Total | 1535 (1,442, 1,625) | 914 (842, 985) | 631 (570, 692) | 226 (192, 260) | 3305 (3169, 3441) |